<DOC>
	<DOCNO>NCT00002644</DOCNO>
	<brief_summary>RATIONALE : Estrogen stimulate growth breast cancer cell . Hormone therapy use tamoxifen may fight breast cancer block uptake estrogen . PURPOSE : Randomized double-blinded phase III trial compare effectiveness tamoxifen placebo prevent breast cancer woman high risk .</brief_summary>
	<brief_title>Tamoxifen Prevention Breast Cancer High-Risk Women</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate whether tamoxifen take daily 5 year reduce incidence mortality breast cancer high-risk woman . II . Assess risk benefit intervention . OUTLINE : This randomize , double-blind , placebo-controlled study . Participants stratify participate institution . Participants randomly assign receive either oral tamoxifen oral placebo every day 5 year absence breast cancer development pregnancy . Participants follow every 6 month 5 year ; annually 5 year . Peer Reviewed Funded Endorsed Cancer Research UK PROJECTED ACCRUAL : 7,000 woman enter rate 200-500 women/institution/5 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : See General Eligibility Criteria PATIENT CHARACTERISTICS : Age : 35 70 Sex : Women Menopausal status : Pre , peri , postmenopausal Performance status : Not specify Life expectancy : At least 10 year Cardiovascular : No prior deep vein thrombosis Pulmonary : No prior pulmonary embolus Other : Psychologically physically able undertake therapy 5 year No medical condition serious risk breast cancer No prior cancer except : Nonmelanomatous skin cancer In situ cancer cervix No pregnant woman Effective nonhormonal contraception require fertile woman PRIOR CONCURRENT THERAPY : Hormone replacement therapy menopausal symptom allow low effective dose Not currently tamoxifen Not currently anticoagulant</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>breast cancer</keyword>
</DOC>